Denosumab treatment and infection risks in patients with osteoporosis: propensity score matching analysis of a national-wide population-based cohort study

Overview of attention for article published in Frontiers in endocrinology, May 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 19,190 followers.

RT @tak_pom: 骨粗鬆症患者におけるデノスマブ治療と感染リスク：台湾のコホート研究 →デノスマブを受けた患者は、以下のリスク[aHR]が高かった。肺炎およびインフルエンザ1.33、尿路感染症1.36、結核1. 60、真菌感染1.67、カンジダ症1.68、帯状疱疹…

18 Apr 2024

Reply Repost Favourite

骨粗鬆症患者におけるデノスマブ治療と感染リスク：台湾のコホート研究 →デノスマブを受けた患者は、以下のリスク[aHR]が高かった。肺炎およびインフルエンザ1.33、尿路感染症1.36、結核1. 60、真菌感染1.67、カンジダ症1.68、帯状疱疹感染1.27、敗血症1.54、死亡1.26 https://t.co/iGmLhGAfDz

18 Apr 2024

Reply Repost Favourite

RT @tak_pom: Front Endocrinol (Lausanne). 2023 May 19:14:1182753. https://t.co/iGmLhGAfDz

22 Feb 2024

Reply Repost Favourite

Front Endocrinol (Lausanne). 2023 May 19:14:1182753. https://t.co/iGmLhGAfDz

19 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.